Health Minister Fahrettin Koca said in a tweet that Turkey has signed a deal with BioNTech, the German firm behind the mRNA-based coronavirus vaccine, for up to 30 million doses of the jab.
The current stock stands at 550,000 doses and Turkey will get 4.5 million doses by the end of March, Koca added.
“According to our deal, up to 30 million doses will be provided under the same conditions,” he said.
Koca also revealed the reason for the delay in the deal between Turkey and the company.
“The reason for the delay was the fact that the producer did not accept any responsibility with regards to potential problems that could arise from the production,” he said, adding that the disagreement was later solved. “Citizens who would like to get a dose will be asked for an informed consent,” he said.
Koca also thanked Turkish-German Professor Uğur Şahin, a co-founder of the BioNTech.
